In order to further explore the effect of ADM2 and RAMP2 on breast cancer cells, siRNAs of ADM2 and the overexpression vector for RAMP2 were constructed and transfected into BT-549 and MDA-MB-231 breast cancer cell lines, respectively. This evidence concerns the gene RAMP2 and breast carcinoma.